Journal article
Using a Participation Monitoring Database to Enhance Recruitment in a Rare Cancer Population
Journal of clinical and translational science, Vol.10(1), e40
2026
DOI: 10.1017/cts.2026.10703
PMCID: PMC12975625
PMID: 41822553
Abstract
Introduction Recruitment for rare disease studies is challenging due to small eligible populations. Traditional clinical research management systems often lack tools to track recruitment contacts prior to enrollment. The NET-PRO study, focused on neuroendocrine tumors (NETs), implemented a participation monitoring system to enhance recruitment efficiency and representativeness. Methods NET-PRO is a multi-center cohort study of 2,538 adults diagnosed with gastroenteropancreatic or lung NETs between January 2018 and September 2024. Recruitment occurred from January 2022 to February 2025 across 14 U.S. medical centers. Sites used flexible recruitment methods (email, mail, phone, in-clinic) and tracked contacts using REDCap-based tools. Participant characteristics were analyzed by enrollment mode (online or mail) and recruitment difficulty (number of contacts required prior to enrollment) using standardized mean differences, chi-square tests, and ANOVA. Results Of 9,279 contacted patients, 2,675 consented (28.8%) and 2,538 enrolled (27.4%). Most enrolled online (83.2%), while 16.8% enrolled by mail. Mail respondents were older, had lower education and income, and more comorbidities. Among those enrolled, Recruitment difficulty was associated with older age, lower education and income, but not comorbidity. Over half of the most difficult-to-recruit participants enrolled online. Contact methods varied by attempt, with email dominating early contacts and phone/mail used more in later attempts. Conclusions A participation monitoring tool supported flexible, multi-modal recruitment and improved sample representativeness in a rare cancer study. Tracking recruitment contacts enabled adaptive strategies and may reduce bias in observational research by enabling better outreach to harder-to-reach populations.
Details
- Title: Subtitle
- Using a Participation Monitoring Database to Enhance Recruitment in a Rare Cancer Population
- Creators
- Michael A. O'rorke - Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, United StatesBrian M. Gryzlak - University of IowaTao Xu - University of Iowa, EpidemiologyBradley D. Mcdowell - University of IowaRhonda R. Decook - University of IowaNicholas J. Rudzianski - University of IowaKimberly C. Serrano - College of Public Health, Department of Epidemiology, University of Iowa, Iowa City, IA, United StatesAbigayle M. Wehrheim - College of Public Health, Department of Epidemiology, University of Iowa, Iowa City, IA, United StatesUdhayvir S. Grewal - University of IowaChandrikha Chandrasekharan - The University of Texas MD Anderson Cancer CenterJoseph S. Dillon - University of IowaThorvardur R. Halfdanarson - Mayo ClinicMichael J. Schnell - Mayo ClinicCarrie L. Witter - Mayo ClinicT. Clark Gamblin - Medical College of WisconsinSyed Kazmi - The University of Texas Southwestern Medical CenterLindsay G. Cowell - The University of Texas Southwestern Medical CenterTobias Else - University of MichiganHeloisa P. Soares - Huntsman Cancer InstituteVineeth Sukrithan - The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research InstituteSravani Chandaka - University of Kansas Medical CenterHanna K. Sanoff - University of North Carolina at Chapel HillFiona C. He - Allina HealthDavid A. Geller - University of PittsburghRobert A. Ramirez - Vanderbilt University Medical CenterMei Liu - University of FloridaWilliam Lancaster - Medical University of South CarolinaJosh A. Mailman - NorCal CarciNET Community, Oakland, CA, United StatesHeather Moran - The Healing NET Foundation, Los Angeles, CA, United StatesMaryann Wahmann - The MillElyse Gellerman - Neuroendocrine Tumor Research FoundationElizabeth A. Chrischilles - University of Iowa
- Resource Type
- Journal article
- Publication Details
- Journal of clinical and translational science, Vol.10(1), e40
- DOI
- 10.1017/cts.2026.10703
- PMID
- 41822553
- PMCID
- PMC12975625
- NLM abbreviation
- J Clin Transl Sci
- ISSN
- 2059-8661
- eISSN
- 2059-8661
- Publisher
- CAMBRIDGE UNIV PRESS; CAMBRIDGE
- Grant note
- Patient-Centered Outcomes Research Institute (PCORI) Award: RD-2020C2-20329 National Center for Advancing Translational Sciences of the National Institutes of Health: UM1TR004403, P30 CA086862
Research reported in this paper is funded through a Patient-Centered Outcomes Research Institute (PCORI) Award (RD-2020C2-20329); the National Center for Advancing Translational Sciences of the National Institutes of Health (UM1TR004403); and shared resources administered under a Cancer Center support Grant (P30 CA086862). The content is solely the responsibility of the authors and does not necessarily represent the official views of PCORI, or the National Institutes of Health.
- Language
- English
- Electronic publication date
- 02/13/2026
- Date published
- 2026
- Academic Unit
- Pharmacy; Epidemiology; Pathology; Fraternal Order of Eagles Diabetes Research Center; Endocrinology and Metabolism; Holden Comprehensive Cancer Center; Internal Medicine
- Record Identifier
- 9985139300302771
Metrics
3 Record Views